BioSpace News Archive

Debiopharm announced that it has entered a clinical collaboration with MEDSIR, a Spanish and US-based, international and innovative research organization in clinical oncology.

NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, will showcase its versatile lung solution and its COMPASS® Hematopathology Services portfolio at the American Society of Clinical Oncology (ASCO) conference in Chicago, May 31–June 4 (booth #31093).

Amarin Corporation plc (NASDAQ:AMRN) today announces that the Greek Ministry of Health has approved VAZKEPA.

Leveragen, Inc. announced today that it has entered into a multi-target commercial license agreement with 92Bio, Inc., a biotech firm focused on the development of therapeutic antibodies.

Coya Therapeutics, Inc. announces that MSCI has selected the Company’s shares for inclusion in its MSCI USA Micro Cap Index at the market close of May 31, 2024.

Evaxion Biotech A/S provides business update and announces first quarter 2024 financial results.

CIONIC, the neurotech inventor pioneering bionic clothing, today announced data showcasing the impact of the FDA-cleared Cionic Neural Sleeve as assistive technology for individuals experiencing difficulty walking due to multiple sclerosis (MS).

CureVac N.V. today announced dosing of the first participant in a Phase 2 study of the multivalent seasonal influenza vaccine candidate developed in collaboration with GSK.

Lisata Therapeutics, Inc. today announced that management will participate in the following events in June.

NRx Pharmaceuticals, Inc. announced presentation of its Phase 2b/3 trial of NRX-101, entitled “A Randomized, Double-Blind Controlled Comparison of NRX-101 to Lurasidone for Adults with Bipolar Depression and Subacute Suicidal Ideation or Behavior” at the American Society of Clinical Psychopharmacology in Miami Beach, FL.